Misyo (Methadone Hydrochloride)

Methadone Hydrochloride, the active ingredient in Misyo, is a synthetic opioid presented as an oral formulation for oral use. It treats moderate to severe chronic pain and supports opioid dependence maintenance therapy in adults.

GNH USA supplies Misyo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methadone Hydrochloride is employed in the management of pain and opioid dependence, acting on the central opioid pathways.

- Moderate to severe chronic pain: provides long‑acting analgesia for patients requiring sustained opioid control. - Opioid dependence: used in maintenance therapy to reduce withdrawal symptoms and cravings, facilitating recovery. - Palliative care: offers symptom relief for patients with advanced disease requiring opioid analgesia. - Post‑operative pain: may be utilized when prolonged opioid analgesia is indicated.

Methadone Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Constipation: reduced gastrointestinal motility. - Nausea: upset stomach often occurring after dosing. - Drowsiness: increased sedation, especially at higher doses. - Sweating: excessive perspiration, particularly during dose adjustments.

Serious or Rare Side Effects: - Respiratory depression: marked reduction in breathing effort, potentially life‑threatening. - QT interval prolongation: cardiac electrical disturbance that can lead to arrhythmia. - Severe hypotension: sudden drop in blood pressure causing dizziness or fainting.

When prescribing or dispensing Methadone Hydrochloride, several safety considerations are essential.

- Dose titration: adjust gradually under medical supervision to minimize overdose risk. - Respiratory monitoring: closely observe patients with compromised breathing function. - Concomitant CNS depressants: avoid or use with caution due to additive sedation. - Pregnancy: risk category unknown; weigh potential benefits against fetal risks. - Store at ambient temperature: keep in original container, protect from moisture and light.

Methadone Hydrochloride interacts with several drug classes; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Other opioids: combined use can cause severe respiratory depression. - Benzodiazepines: additive central nervous system depression increases sedation risk. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise methadone plasma concentrations.

Moderate Interactions (Monitor Closely): - CYP2B6 inducers (e.g., rifampin): may lower methadone levels, reducing efficacy. - QT‑prolonging agents (e.g., macrolide antibiotics): additive risk of cardiac arrhythmias. - Alcohol: enhances sedative effects and may impair respiration.